Literature DB >> 23365589

Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Michelle Barton1, Michael Hawkes, Dorothy Moore, John Conly, Lindsay Nicolle, Upton Allen, Nora Boyd, Joanne Embree, Liz Van Horne, Nicole Le Saux, Susan Richardson, Aideen Moore, Dat Tran, Valerie Waters, Mary Vearncombe, Kevin Katz, J Scott Weese, John Embil, Marianna Ofner-Agostini, E Lee Ford-Jones.   

Abstract

Entities:  

Year:  2006        PMID: 23365589      PMCID: PMC3555463     

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  151 in total

1.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.

Authors:  John M Boyce; Didier Pittet
Journal:  Am J Infect Control       Date:  2002-12       Impact factor: 2.918

2.  Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999.

Authors:  Andrew E Simor; Marianna Ofner-Agostini; Elizabeth Bryce; Allison McGeer; Shirley Paton; Michael R Mulvey
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

3.  Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children.

Authors:  Kevin Purcell; Jaime E Fergie
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

4.  Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.

Authors:  Farrin A Manian
Journal:  Clin Infect Dis       Date:  2003-01-06       Impact factor: 9.079

5.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 6.  Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.

Authors:  E Anne Eady; Jonathan H Cove
Journal:  Curr Opin Infect Dis       Date:  2003-04       Impact factor: 4.915

7.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

Authors:  Philippe Dufour; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Hervé Richet
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

8.  Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

Authors:  Arthur L Frank; John F Marcinak; P Daisy Mangat; Joyce T Tjhio; Swathi Kelkar; Paul C Schreckenberger; John P Quinn
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

9.  Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children.

Authors:  Carlos A Sattler; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

10.  Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

Authors:  Cassandra D Salgado; Barry M Farr; David P Calfee
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

View more
  35 in total

1.  Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.

Authors:  M-J Milloy; Evan Wood; Elisa Lloyd-Smith; Eric Grafstein; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Community Health       Date:  2010-12

2.  Community-associated MRSA: superbug at our doorstep.

Authors:  Michael Hawkes; Michelle Barton; John Conly; Lindsay Nicolle; Clare Barry; Elizabeth L Ford-Jones
Journal:  CMAJ       Date:  2007-01-02       Impact factor: 8.262

Review 3.  Prevention and control of infections in the home.

Authors:  John M Embil; Brenda Dyck; Pierre Plourde
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

Review 4.  Control of antibiotic-resistant bacteria in the office and clinic.

Authors:  Anne G Matlow; Shaun K Morris
Journal:  CMAJ       Date:  2009-05-12       Impact factor: 8.262

5.  Community-associated methicillin-resistant Staphylococcus aureus: Implications for the care of children.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-04       Impact factor: 2.253

6.  Community-associated methicillin-resistant Staphylococcus aureus: Continuing to evolve.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

7.  Sensitivities of nasal and rectal swabs for detection of methicillin-resistant Staphylococcus aureus colonization in an active surveillance program.

Authors:  Andrea Currie; Linda Davis; Ewa Odrobina; Suzanne Waldman; Diane White; Joanne Tomassi; Kevin C Katz
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

8.  Community-associated methicillin-resistant Staphylococcus aureus: Implications for the care of children.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

9.  Treatment of septic arthritis.

Authors:  Cheryl Main
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

Review 10.  Whole-genome sequencing in outbreak analysis.

Authors:  Carol A Gilchrist; Stephen D Turner; Margaret F Riley; William A Petri; Erik L Hewlett
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.